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Many glycoproteins of enveloped viruses as well as cellular proteins are covalently modified with fatty acids. Palmitoylation
is often reversible, but the enzymology of this hydrophobic protein modification is not understood. Recently a cytosolic
enzyme designated acyl-protein thioesterase 1 (APT1) was purified, which depalmitoylates several cellular proteins. Since
hitherto no transmembrane proteins have been tested as substrates for APT1 we have investigated whether palmitoylated
viral membrane glycoproteins can be deacylated by use of this enzyme. Recombinant APT1 was purified from Escherichia
coli, and depalmitoylation of [3H]palmitate-labeled glycoproteins present in virus particles was measured by SDS–PAGE,
fluorography, and scanning densitometry. We find that APT1 causes rapid and almost complete cleavage of fatty acids from
the G-protein of vesicular stomatitis virus, hemagglutinin proteins of influenza A and C virus, and E2 of Semliki Forest virus
(SFV). In contrast, E1 of SFV is largely resistant against APT1 activity. This substrate specificity of APT1 was also observed
using microsomes prepared from SFV-infected cells. Our data emphasize the potential of APT1 as a tool for functional
analysis of protein-bound fatty acids. © 2001 Academic PressKey Words: palmitoylation; acyl-protein thioesterase; viral glycoproteins; influenza virus; hemagglutinin; Semliki Forest
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INTRODUCTION
Most enveloped viruses contain at least one spike
glycoprotein covalently modified with fatty acids
(Schlesinger et al., 1993). Well-characterized examples
are the hemagglutinin (HA) of influenza virus, the G-
protein from vesicular stomatitis virus (VSV), and the E1
and E2 glycoproteins of Semliki Forest virus (SFV)
(Schmidt, 1982; Schmidt and Schlesinger, 1979). The gly-
coproteins are palmitoylated at conserved cysteine res-
idues located at the border region between the trans-
membrane domain and the cytoplasmic (intraviral) tail
(Rose et al., 1984; Veit et al., 1991). A consensus se-
quence is apparently not required for palmitoylation, but
specific amino acids in the transmembrane region and
the cytoplasmic tail modulate the efficiency of palmitoyl-
ation (Ponimaskin and Schmidt, 1998).
Despite numerous studies, the function of palmitoyl-
ation of viral glycoproteins is still unclear. Most research-
ers used recombinant DNA technology to eliminate the
fatty acid-binding sites in viral glycoproteins. The result-
ing viruses/glycoproteins are often impaired in their bi-
ological properties such as fusion and/or budding from
host cell membranes (Caballero et al., 1998; Fischer et
1 To whom correspondence and reprint requests should be ad-
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89al., 1998; Ivanova and Schlesinger, 1993; Naeve and
Williams, 1990; Ryan et al., 1998; Zhang et al., 2000;
Zurcher et al., 1994). In contrast, others have found no
effect with such depalmitoylated proteins (Holsinger et
al., 1995; Jin et al., 1996; Naim et al., 1992; Steinhauer et
al., 1991; Veit et al., 1991; Whitt and Rose, 1991). More
detailed functional studies with palmitoylated and non-
acylated proteins in vitro have not been amenable be-
cause gentle methods to depalmitoylate proteins are not
available. Chemical deacylation of glycoproteins with
hydroxylamine can lead to unpredictable side effects
causing loss of function not attributable to palmitoylation
(Philipp et al., 1995).
Though protein palmitoylation is often a reversible
process with cycles of acylation and deacylation (Dun-
phy and Linder, 1998; Resh, 1999), it has not been directly
demonstrated for viral proteins. Enzymes involved in pal-
mitoylation and depalmitoylation of viral as well as cel-
lular proteins have not been identified with certainty.
Recently, progress has been reported for the study of
enzymology of depalmitoylation of cellular proteins. Us-
ing palmitoylated a-subunits of heterotrimeric G-proteins
s substrate, an enzyme with depalmitoylating activity
as purified from rat liver and designated acyl-protein
hioesterase 1 (APT1) (Duncan and Gilman, 1998). Endo-
helial nitric oxide synthetase (e-NOS) is also a substrate
or this enzyme (Yeh et al., 1999). Peptide sequencing of
PT1 revealed that it is identical to rat lysophospho-
ipase, an enzyme purified previously by others (Sugi-
0042-6822/01 $35.00
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D SCmoto et al., 1996). APT1 also hydrolyzes palmitoyl-coen-
zyme A (Pal-CoA), the lipid substrate for palmitoylation.
Although APT1 is multifunctional, experimental compar-
ison of its Km values for the acyl cleavage in Gas, Lyso-
PC, and Pal-CoA revealed that acylproteins are the
preferred substrate, at least in vitro (Duncan and Gilman,
1998). The crystal structure of APT1 was published re-
cently, providing insights into the catalytic mechanism of
the enzyme (Devedjiev et al., 2000).
APT1/lysophospholipase is a cytosolic protein with a
molecular mass of 25 kDa. It is expressed in every
mammalian cell type examined and homologues have
been identified in lower organisms such as Saccharo-
myces cerevisiae and Caenorhabditis elegans (Duncan
nd Gilman, 1998; Sugimoto et al., 1996). Here we show
for the first time that recombinant APT1 purified from
Escherichia coli can release fatty acids from palmitoy-
lated viral glycoproteins indicating that this enzyme op-
erates also on typical transmembrane proteins.
RESULTS AND DISCUSSION
Testing APT1 activity on palmitoylated glycoproteins
of Semliki Forest virus
SFV was grown in BHK cells in the presence of
[3H]palmitate and virus particles were purified from cell
ulture supernatants. SFV contains the glycoproteins E1
nd E2 in equimolar amounts, but E2 is more heavily
abeled with [3H]palmitate (compare Figs. 1B and 1C and
Mancini et al. (2000)). This is consistent with the identi-
fication of four versus only one palmitoylation site(s) in
E2 and E1, respectively (Ivanova and Schlesinger, 1993;
Schmidt et al., 1988).
To test whether E1 and E2 are substrates for APT1,
recombinant 6xHis-APT1 was purified from E. coli (see
Fig. 1A) and incubated at various concentrations (0.01 to
10 mg) with SFV particles (120 mg) in the presence of
Triton X-100. The assay was stopped after 30 min with
nonreducing SDS–PAGE buffer and samples were sub-
jected to electrophoresis followed by Coomassie stain-
ing (Fig. 1B). The fluorogram of the stained gel revealed
that the APT1 cleaves the fatty acids from the E2 glyco-
protein in a concentration-dependent manner (Fig. 1C).
One microgram of APT1 present in the assay was suffi-
cient for an almost quantitative cleavage. In contrast,
almost 80% of the fatty acids bound to the E1 glycopro-
tein remain stably attached even after treatment with 10
mg of APT1.
Cleavage of fatty acids from E2 was successfully abol-
ished by either boiling of APT1 prior to the assay (data
not shown) or substituting the denaturing detergent SDS
(0.2%) for Triton X-100 (Fig. 1C, sample designated 10SDS).
This underscores the enzymatic nature of the reaction,
as the cleavage of fatty acids from viral spikes requires
90 VEIT ANthe presence of a nondenaturing detergent like Triton
X-100. Virus particles incubated with APT1 in the ab-
w
Asence of Triton failed to show fatty acid cleavage (see
Fig. 3, top, lane designated 402). When whole virus
particles were used as protein substrate, Triton X-100
was required to solubilize the viral membrane and make
the intraviral fatty acid-binding sites accessible to APT1.
We tested this assumption with substrate proteins in
which the fatty acid-binding sites are accessible to APT1
in the absence of detergent, i.e., SFV glycoproteins
present in microsomes of virus-infected cells. BHK cells
infected with SFV were labeled overnight with [3H]palmi-
ate, and microsomes were prepared and incubated with
PT1. The resulting fluorogram revealed significant
leavage (;60%) of fatty acids from E2, but not from E1
see Fig. 2). Thus, it is observed that the activity of APT1
oes not require detergent and the preference of APT1
or E2 is preserved under those conditions. Microsomes
FIG. 1. Depalmitoylation of E1 and E2 of Semliki Forest virus with
APT1. (A) Purification of 6xHis-APT1 from E. coli cells. The Coomassie
staining of two eluates from the nickel-affinity column is shown. (B and
C) [3H]Palmitate-labeled Semliki Forest virus (120 mg total protein) was
ncubated with 1% Triton X-100 and increasing amounts of APT1 (0.01
o 10 mg) for 30 min at 30°C. Samples were then subjected to SDS–
PAGE under nonreducing conditions followed by Coomassie staining
(B) and fluorography (C). One sample contained SDS (0.2%) instead of
Triton. The two glycoproteins of SFV and the nonpalmitoylated capsid
protein are designated E1, E2, and C, respectively. Coomassie-stained
bands marked with an asterisk are probably due to the formation of
intramolecular disulfide bonds after cleavage of fatty acids from E2
(see Results). (D) [3H]Palmitate-labeled Semliki Forest virus was incu-
bated with 10 mg APT1 in the presence of 1% Triton X-100 and increas-
ing concentrations of calcium chloride or magnesium chloride for 30
min at 30°C. Samples were then subjected to SDS–PAGE and fluorog-
raphy with a 5-day exposure.
HMIDTere also incubated in the presence of Triton X-100 with
PT-1, which resulted in a complete cleavage of fatty
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AL GLacids from E2 (data not shown). However, the detergent
requirement of APT1 cannot be determined exactly with
this assay because Triton X-100 might also unveil addi-
tional palmitoylation sites that otherwise are buried in
the bilayer or masked by interactions with other proteins.
It has been described that calcium at millimolar con-
centrations potentiates depalmitoylation of endothelial
nitric oxide synthase (e-NOS; Yeh et al., 1999), whereas
no effect of calcium was detectable on depalmitoylation
of a-subunits of heterotrimeric G-proteins (Duncan and
Gilman, 1998). Therefore we tested the effect of calcium
and another divalent cation (magnesium) on depalmitoy-
lation of E1 and E2 of Semliki Forest virus. We found no
divalent cation requirement for deacylation of viral gly-
coproteins (see Fig. 1D). In contrast at nonphysiological
concentrations (10 mM) divalent cations inhibited fatty
acid cleavage from the E2 glycoprotein and also the
deacylation of G-protein of VSV and of HEF protein of
influenza C virus (see Fig. 4). Therefore it seems unlikely
that calcium stimulates the thioesterase activity of APT1
in general as suggested by the initial data with e-NOS,
but rather its effect depends on the acylprotein under
investigation.
To compare the efficiency of enzymatic deacylation of
the two structural proteins E1 and E2, SFV was incubated
with 10 mg of APT1 for different periods of time (1 to 40
min) and the resulting fluorograms were quantified by
scanning densitometry. As apparent from Fig. 3, a 5-min
incubation resulted in the cleavage of more than 60% of
FIG. 2. APT1 activity with microsomes prepared from SFV-infected
ells. Microsomes were prepared from [3H]palmitate-labeled cells in-
fected with SFV or from uninfected cells. Microsomes (200 mg) were
incubated without or with APT1 (10 mg) for 30 min at 30°C and samples
ere subjected to SDS–PAGE and fluorography.
DEPALMITOYLATION OF VIRfatty acids from E2 and after 20 min the reaction reached
saturation with more than 90% cleavage of E2-bound Efatty acids. In contrast, cleavage of fatty acids from E1 is
quite slow. It was barely detectable after 5 min and only
25% of E1-linked fatty acids were cleaved after 40 min of
incubation time. The results presented in Figs. 1 to 3
provide conclusive evidence that APT1 works with differ-
ent efficiencies on E1 and E2 of Semliki Forest virus.
Similar results were obtained for E1 and E2 glycoproteins of
the closely related Sindbis virus (data not shown).
The kinetics of fatty acid cleavage from E2 were sim-
ilar to those reported for the a-subunits of hetereotrim-
ric G-proteins and for the ras protein. However, only
0% of covalently linked fatty acids were cleaved from
oth cellular proteins (Duncan and Gilman, 1998).
It was surprising to find that relatively large amounts (1
mg) of APT1 were required to obtain cleavage of protein-
bound fatty acids. Our calculations showed the enzyme:
substrate ratio for this reaction to be about 1:80 and
published data on enzyme:substrate ratios with cellular
acylproteins and recombinant APT1 revealed compara-
ble values. The native enzyme purified from rat liver has
a slightly lower enzyme:substrate ratio (Duncan and Gil-
man, 1998).
FIG. 3. Kinetics of depalmitoylation of E2 and E1 of SFV with APT1. E2
and E1 of Semliki Forest virus are deacylated at different rates and to
a different extent. [3H]Palmitate-labeled SFV (120 mg total protein) was
incubated with 10 mg APT1 for 0 to 40 min in the presence of 1% Triton
X-100. No Triton was present in one sample incubated for 40 min (lane
marked 402). Samples were then subjected to SDS–PAGE and fluorog-
raphy (top). The rate of depalmitoylation was calculated by scanning
densitometry analysis of the resulting fluorogram. Time of incubation is
91YCOPROTEINS WITH APT1plotted against relative amount of 3H-labeled fatty acids remaining on
1 and E2 glycoproteins (bottom).
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proteins
We have reported recently that E1 and E2 are acylated
with different fatty acid species. It was found that E2
contained mainly palmitic acid, and E1 acylated predom-
inantly with stearic acid (Veit et al., 1996). Thus, with the
results shown in Figs. 1 to 3, it may be conceived that
APT1 has a preference for palmitate as protein-bound
fatty acid over longer acyl chains. Therefore we investi-
gated whether APT1 cleaves fatty acids from the HEF
glycoprotein of influenza C virus, another glycoprotein
acylated predominantly with stearic acid (Veit et al., 1990,
1996). In contrast to E1, HEF proved to be a good sub-
strate for APT1 (see Fig. 4, left). Complete cleavage of
fatty acids was obtained with 10 mg of APT1 and approx-
mately 65% cleavage was detectable with 1 mg of the
enzyme. However, the possibility cannot be excluded
that the 3H-labeled fatty acid content of viral glycopro-
teins varies from preparation to preparation, possibly
due to varying metabolism of externally added [3H]palmi-
ate. Therefore we analyzed the 3H-labeled fatty acid
ontent of E1 and E2 of SFV and of HEF of influenza C
irus from the same virus preparations that were used in
he deacylation experiments with APT1. [3H]Palmitate-
labeled glycoproteins were purified by SDS–PAGE and
cut from the gel, and fatty acids were liberated with 6 N
FIG. 4. Depalmitoylation of HEF protein of influenza C virus and of G
C virus (left) and vesicular stomatitis virus (VSV, right), was incubated
-100 (1% final concentration) for 30 min at 30°C. One sample also c
SDS–PAGE under nonreducing conditions with subsequent Coomassie
and G are the membrane glycoproteins and NP and N are the nucleocap
bands representing the suspected G-protein dimer (lanes 1 and 2) an
reducing conditions.
92 VEIT ANHCl and extracted with hexane. Thin-layer chromatogra-
phy revealed that both E1 and HEF contain almost ex-clusively [3H]stearic acid, whereas E2 is acylated mainly
with [3H]palmitic acid (see Fig. 5). Thus, it is unlikely that
the inefficient cleavage of fatty acid from E1 of SFV is due
to its predominant acylation with stearic acid.
In extending our study of APT1 action on other well-
characterized viral glycoproteins, we found that both the
in of VSV. 100 mg of total protein, from [3H]palmitate-labeled influenza
creasing amounts of APT1 in the absence (102) or presence of Triton
d calcium chloride (10 mM, 101Ca). Samples were then subjected to
(A) and fluorography (B). Viral proteins are designated as follows: HEF
teins of influenza C virus and VSV, respectively. (C) Coomassie-stained
omer (lane 3) in A were excised and subjected to SDS–PAGE under
FIG. 5. Fatty acid analysis of viral glycoproteins. Glycoproteins from
[3H]palmitate-labeled SFV and Flu C preparations were purified by
SDS–PAGE, and protein-bound fatty acids were liberated with 6 N HCl,
extracted with hexane, and subjected to TLC analysis and fluorography.
Identity of bands was confirmed with radioactive reference substances
run on the same TLC plate. E1 and E2 are the glycoproteins from SFV;
HEF is the glycoprotein from Flu C. The band marked with an asterisk
HMIDT-prote
with in
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AL GLG-protein of vesicular stomatitis virus (Fig. 4, right) and
the hemagglutinin (HA) of influenza A virus (strains virus
N and fowl-plaque virus; data not shown) act as sub-
strates for this deacylating enzyme. Complete cleavage
of fatty acids from 150 mg of VSV particles was obtained
ith 1 mg of APT1.
Close inspection of Coomassie-stained gels after
AGE separation of influenza C virus and VSV proteins
evealed the appearance of an additional band of high
olecular weight in the APT1-treated samples (bands
esignated Dimer in Fig. 4A). The intensity of Coomassie
taining of the authentic bands of G and HEF protein
onomers decreased simultaneously with the appear-
nce of this new suspected dimer band. Thus, it is likely
hat with both influenza C and VSV proteins, the high-
olecular-weight material consists of disulfide-linked
ligomers of HEF and G, respectively, which persist
uring electrophoresis under nonreducing conditions.
he disulfide bonds yielding dimers are formed only
hen free cysteine residues become available after fatty
cid cleavage. In order to prove this assumption, the
igh-molecular-weight bands (marked 1 and 2 in Fig. 4)
nd the G-protein band (marked 3) were excised from the
el and subjected to electrophoresis under reducing
onditions. As expected, both the new high-molecular-
eight band and the authentic G-protein run to the same
osition after the disulfide bonds are reduced (see Fig.
C). Bands corresponding to oligomers of E2 were not
bserved with APT1-treated Semliki Forest virus prepa-
ations. Instead, there is a slight reduction in the elec-
rophoretic mobility of this protein (see Fig. 1, bands
arked with an asterisk). E2 contains four palmitoylation
ites and therefore it is likely that intramolecular instead
f intermolecular disulfide bonds are formed after fatty
cid cleavage, which makes the protein run faster.
Our data show that most acylated viral glycoproteins
re good substrates for APT1 in vitro. Almost complete
cleavage of fatty acids was obtained with E2 of Semliki
Forest virus, HA and HEF of influenza viruses, and the
G-protein of vesicular stomatitis virus. Using these mem-
brane proteins as substrate, the enzyme:substrate ratio
to obtain cleavage was relatively high, but on the same
order of magnitude as published results with cellular
acylproteins and lower than that for the Pal-CoA hydro-
lase activity of APT1. In contrast to all other viral acyl-
proteins tested, E1 of SFV is apparently a poor substrate
for APT1. This indicates that APT1 does not work on
every palmitoylated protein with the same efficiency.
It is well established that palmitoylation of several
cellular acylproteins is reversible with cycles of acylation
and deacylation (Resh, 1999). In contrast, cleavage of
fatty acids was not observed for viral glycoproteins in
transit from the endoplasmic reticulum to the plasma
membrane and purified viral glycoproteins contain fatty
DEPALMITOYLATION OF VIRacids in stoichiometric amounts (Schmidt and Schles-
inger, 1979; Veit and Schmidt, 1993). It is therefore un-
(
wlikely that APT1 is active on viral glycoproteins in virus-
infected cells. We have found that the fatty acid-binding
sites of E2, present in microsomes prepared from SFV-
infected cells, are accessible to APT1. Thus the question
arises as to why viral glycoproteins are good substrates
for APT1 in vitro (even better than the cellular acylpro-
teins tested so far), but apparently not in vivo. An appar-
ent possibility would be that APT1 and viral glycoproteins
localize to different cellular compartments. However,
APT1 was purified from the cytosol and therefore it
should have access to the palmitoylation sites located in
the cytoplasmic tail of viral glycoproteins. One possible
explanation would be that the fatty acids are protected by
association of the cytoplasmic tail with other viral mem-
brane proteins, e.g., with the matrix protein in the case of
influenza viruses and with the capsid protein for SFV.
Clearly, the function of APT1 in vivo, its substrates, and
its regulation need to be more precisely defined. How-
ever, despite the present lack of evidence for a physio-
logical role of APT1 for viral glycoproteins, the enzyme
could prove to be a potent tool for gentle depalmitoyla-
tion of proteins in vitro. Replacing the method of chem-
ical deacylation with hydroxylamine by use of enzymatic
deacylation of proteins with APT1 may stimulate
progress in future studies of the biological functions of
protein-linked fatty acids. With APT1 operating on viral
membrane proteins it may also prove useful for functional
studies of the many palmitoylated membrane receptors.
MATERIALS AND METHODS
Buffers
TN buffer consists of 20 mM Tris/HCl; 150 mM NaCl at
pH 7.4; wash buffer consists of TN with 10 mM imidazol;
elution buffer was TN with 100 mM imidazol; sonication
buffer was TN with 1 mM PMSF. TNE buffer contains 20
mM Tris/HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA. SDS–
PAGE sample buffer (nonreducing, final concentration)
contains 62.5 mM Tris/HCl, pH 6.8, 2% SDS, 10% glycerol.
The reducing sample buffer contains 5% b-mercapto-
thanol.
urification of recombinant APT1 from E. coli
XL-1 blue E. coli cells transformed with pQE60 plasmid
Qiagen, Hilden, Germany) containing the APT1 gene
Duncan and Gilman, 1998) were grown in medium con-
aining ampicillin (50 mg/ml) to an optical density of 0.6.
IPTG (final concentration of 1 mM) was added and the
cells were grown for an additional 16 h at 37°C. Cells
were pelleted (10 min at 5000g) and frozen at 280°C or
rocessed immediately.
All subsequent steps were performed on ice or at 4°C.
. coli cell pellets were resuspended in sonication buffer
93YCOPROTEINS WITH APT15 ml per 100 ml of bacterial culture medium) and cells
ere broken by sonication with an ultrasonic cell dis-
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D SCrupter (three bursts at 5-W setting). Lysozyme (1 mg/ml)
and DNase I (2 mg/ml) were added and samples were
ncubated for 30 min prior to an additional sonication
tep. Triton X-100 was added to a final concentration of
.5% and the solution was stirred for 20 min. Following
nother sonication step, cell debris was pelleted (20 min
t 10,000g) and discarded. The supernatant was incu-
ated for 1 h with Ni–NTA–agarose (Qiagen), with 100 ml
of a 50% slurry used per 500 ml of supernatant. Agarose
with bound proteins was transferred to a column that
was subsequently washed three times with wash buffer.
Proteins were eluted with elution buffer, dialyzed against
TN buffer, and stored at 280°C for further studies. Pro-
tein concentration was determined with the DC protein
assay kit II from Bio-Rad (Munich, Germany), which is
based on the Lowry method. This procedure yields 0.5 to
2.5 mg of protein per milliliter of culture medium. Purity of
roteins was .95% as analyzed by SDS–PAGE and Coo-
assie blue staining (see Fig. 1A).
rowth, labeling, and preparation of virus particles
All procedures applied have been described before
Schmidt, 1982; Schmidt and Schlesinger, 1979; Veit et al.,
990). Briefly, VSV and SFV were grown in BHK cells and
nfluenza viruses were grown in MDCK II cells (influenza
strains: fowl plaque virus (H7) and Virus N (H10)) or
DCK I cells (influenza C virus). Infected cells were
abeled 3 h postinfection with [3H]palmitic acid. Viruses
ere pelleted from the cell culture fluid 16 or 48 h
influenza C) after infection. Virus particles were resus-
ended in TN buffer and stored at 280°C until further
se. The protein concentration was determined with the
C protein assay kit II from Bio-Rad.
reparation of [3H]palmitate-labeled microsomes
rom SFV-infected cells
BHK cells were infected with SFV at 37°C as de-
cribed above and labeled with [3H]palmitate (100
mCi/ml medium) at 3 h postinfection for 14 h. Labeling
was done at 30°C to retard virus growth. Infected cells
were then scraped, pelleted (2000g for 10 min), washed
with PBS, pelleted again, and resuspended in hypotonic
buffer (20 mM HEPES–NaOH, pH 7.4, 50 mM NaCl, 1 mM
EDTA, 1 mM PMSF; 1 mg/ml leupeptin, 1 mM pepstatin).
Cells were broken with 40 strokes in a tight-fitting
douncer. Unbroken cells and large membrane fragments
were pelleted (2000g for 10 min) and the resulting super-
atant was subjected to ultracentrifugation (100,000g for
1 h). The resulting microsomal pellet was resuspended
in TN buffer and stored at 280°C.
Depalmitoylation assay with virus particles and
microsomes from virus-infected cells
94 VEIT ANIn the standard assay 5 to 10 ml of [3H]palmitate-
labeled virus particles (100–300 mg total protein) wasincubated with 10 mg of APT1. TN buffer was added to a
inal volume of 40 ml. Assays also contained Triton X-100
at a final concentration of 1% if not stated otherwise.
Samples were incubated at 30°C for 30 min. Any devia-
tions from this standard assay are indicated in the figure
legends. Microsomes (200 mg) from SFV-infected cells
were incubated with 10 mg of APT1 in a final volume of 40
ml TN buffer in the absence of Triton X-100 at 30°C for
1 h. Reactions were stopped by adding 20 ml of 33
oncentrated nonreducing SDS–PAGE sample buffer.
nalysis of protein-bound fatty acids
Analysis of protein-bound fatty acids was conducted
s described (Veit et al., 1990). Briefly, glycoproteins from
[3H]palmitate-labeled virus preparations were purified by
DS–PAGE and cut from the gel. The dried gel pieces
ere incubated with 6 N HCl for 16 h at 110°C in tightly
ealed ampules. Liberated fatty acids were extracted
hree times with hexane, pooled, and concentrated in a
tream of nitrogen. Separation into individual fatty acid
pecies was done on RP-18 HPTLC plates (Merck,
annheim, Germany) with acetonitrile:acetic acid (1:1)
s solvent system. Radioactivity on the thin-layer plate
as made visible by spraying with En3Hance (Amer-
ham).
DS–PAGE, fluorography, and quantification
Samples were separated by PAGE using 12% SDS gels
nder nonreducing conditions. Gels were stained with
oomassie, destained with 10% ethanol and 10% acetic
cid, washed with distilled water (30 min), and treated
ith 1 M sodium salicylate (30 min). The gels were then
ried and exposed to X-ray film. Film exposure times
ere between 2 and 10 days. For densitometric quanti-
ation of bands on X-ray films with different exposure
imes, we used an Epson scanner GT 9000 and Scan-
ack 3.0 software (Biometra, Go¨ttingen, Germany).
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